Reduced Brain Iron Linked to Striatal Hyperdopaminergia in Schizophrenia: Insights from QSM MRI and PET Imaging

MedXY Editorial Team•Oct 30, 2025•Neurology

Schizophrenia patients exhibit reduced brain iron levels in the substantia nigra and ventral tegmental area (SN-VTA) as measured by quantitative susceptibility mapping MRI.
Lower SN-VTA magnetic susceptibility, reflecting diminished iron, correlates inversely with elevated striatal dopamine synthesis capacity assessed by [18F]-DOPA PET.
The relationship persists after accounting for confounding factors such as neuromelanin and myelin content, underscoring iron’s potential role in dopaminergic dysregulation.
These findings provide novel mechanistic insights into schizophrenia pathophysiology and raise the prospect of targeting brain iron homeostasis in future treatment strategies.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Schizophrenia patients exhibit reduced brain iron levels in the substantia nigra and ventral tegmental area (SN-VTA) as measured by quantitative susceptibility mapping MRI.
Lower SN-VTA magnetic susceptibility, reflecting diminished iron, correlates inversely with elevated striatal dopamine synthesis capacity assessed by [18F]-DOPA PET.
The relationship persists after accounting for confounding factors such as neuromelanin and myelin content, underscoring iron’s potential role in dopaminergic dysregulation.
These findings provide novel mechanistic insights into schizophrenia pathophysiology and raise the prospect of targeting brain iron homeostasis in future treatment strategies.